00:36 , Oct 19, 2018 |  BC Innovations  |  Tools & Techniques

Allogeneic CARs on the horizon

With the first generation of autologous, personalized CAR T cell therapies on the market, the field is turning to allogeneic technologies to provide better scale and lower costs. But drug makers are learning that as...
17:38 , Sep 28, 2018 |  BC Week In Review  |  Clinical News

Cell Medica doses first neuroblastoma patient with NK cell therapy

Cell Medica Ltd. (London, U.K.) dosed the first patient in the open-label, U.S. Phase I GINAKIT2 trial of CMD-501 to treat relapsed or refractory pediatric neuroblastoma, which the company said marks the first use of...
22:18 , Aug 1, 2018 |  BC Extra  |  Company News

Management tracks: Hologic, Tricidia

Hologic Inc. (NASDAQ:HOLX) said Bob McMahon has departed as CFO to become CFO at Agilent Technologies Inc. (NYSE:A). The diagnostics company promoted Chief Accounting Officer Karleen Oberton to CFO. Metabolic acidosis play Tricida Inc. (NASDAQ:TCDA)...
21:37 , Jun 11, 2018 |  BC Extra  |  Company News

Management tracks: Arbutus, Cancer Research UK

HBV company Arbutus Biopharma Corp. (NASDAQ:ABUS) said CFO Koert VandenEnden is stepping down. He is succeeded by David Hastings, who was CFO and EVP at Unilife Corp. Unilife went bankrupt in 2017. Cancer Research UK...
21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
19:34 , May 17, 2018 |  BC Innovations  |  Finance

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized...
23:53 , Feb 20, 2018 |  BC Extra  |  Company News

Management tracks: Cell Medica, Iterum

Cancer immunotherapy company Cell Medica Ltd. (London, U.K.) appointed Kevin Boyle as CFO. He was CFO at FloWorks International LLC (Houston, Texas). Anti-infectives company Iterum Therapeutics Ltd. (Dublin, Ireland) hired Jeff Schaffnit as chief commercial...
23:41 , Dec 12, 2017 |  BC Extra  |  Company News

Management tracks: Achaogen, Minerva

Antibacterial company Achaogen Inc. (NASDAQ:AKAO) said Kenneth Hillan will step down as CEO, effective Jan. 1. He will remain president and president of R&D. Blake Wise, who has served as president and COO, will become...
23:45 , Sep 27, 2017 |  BC Extra  |  Company News

Management tracks: Gilead, Tango, Rubius, Bicycle

Gilead Sciences Inc. (NASDAQ:GILD) said COO Kevin Young will retire, effective early 2018. Young returned to Gilead as COO in May 2016 after brief retirement during which he acted as an advisor. He was Gilead's...
22:53 , May 26, 2017 |  BioCentury  |  Finance

Europe’s bellwether challenge

A healthy biotech ecosystem comprises a continuum from big pharma and bellwether biotechs at the top to private newcos at the bottom, with a mixture of liquidity events -- predominantly M&A -- to reward investors....